Published in Br J Clin Pharmacol on February 01, 1980
Effect of pregnancy on a measure of FMO3 activity. Br J Clin Pharmacol (2005) 0.94
Labetalol disposition and concentration-effect relationships during pregnancy. Br J Clin Pharmacol (1983) 0.77
The metabolism of methimazole in pregnancy. Br J Clin Pharmacol (1980) 0.75
Antiepileptic drugs: metabolism in pregnancy. Clin Pharmacokinet (1979) 1.57
The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. Br J Clin Pharmacol (1980) 1.30
Drug metabolism in thyroid disease. Clin Pharmacokinet (1976) 1.24
Drug kinetics in pregnancy. Clin Pharmacokinet (1977) 1.22
The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab (1977) 1.10
Hyperthyroidism associated with pregnancy. Obstet Gynecol (1974) 0.96
Geriatric patients in an acute medical ward. Br Med J (1975) 5.27
A new hospital discharge letter. Lancet (1973) 4.08
Contraindications to the use of metformin. BMJ (2003) 2.59
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (1996) 2.35
Frequent attenders at a health centre. Practitioner (1974) 2.07
Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab (1967) 1.55
Isotope uptake and scanning of stomach in man with 99mTc-pertechnetate. Lancet (1967) 1.48
Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis. J Clin Endocrinol Metab (1970) 1.46
Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids. Mol Cell Biol (2001) 1.43
Letter: side effects of methyldopa. Br Med J (1975) 1.41
Increased apoptosis induction by 121F mutant p53. EMBO J (1999) 1.41
Patient guidance after 131I therapy: time for change? Lancet (1992) 1.38
A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab (1993) 1.32
Emotion and non-specific infection as possible aetiological factors in Graves' disease. Their relation to thyroid suppressibility. Lancet (1968) 1.30
The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. Br J Clin Pharmacol (1980) 1.30
Association of Thyrotoxicosis and Auto-immune Thyroiditis. Br Med J (1961) 1.20
Cross cultural adaptation and validation of the Chinese Health Assessment Questionnaire for use in rheumatoid arthritis. J Rheumatol (1998) 1.19
Antithyroid drugs. Pharmacol Ther B (1978) 1.17
Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs. Lancet (1966) 1.14
The influence of flow rate on the salivary iodide concentration in man. Arch Oral Biol (1966) 1.13
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem (1988) 1.12
The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab (1977) 1.10
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid. Clin Endocrinol (Oxf) (1975) 1.08
A high-speed liquid chromatographic analysis of indomethacin in plasma. J Chromatogr (1975) 1.08
Sequential assessment during drug treatment of thyrotoxicosis. Clin Endocrinol (Oxf) (1973) 1.08
Primary and specialist care in diabetes. Lancet (1997) 1.07
Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assay. Int J Cancer (1999) 1.07
The effect of insulin on vascular reactivity to norepinephrine. Diabetes (1977) 1.06
[Bruises, loose teeth and fatigue in a patient with schizophrenia]. Ned Tijdschr Geneeskd (2005) 1.06
Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res Suppl (1990) 1.01
Effect of acute alcohol intoxication on the metabolism and plasma kinetics of chlordiazepoxide. Br J Clin Pharmacol (1979) 1.01
Mitotic segregation of viral and cellular acentric extrachromosomal molecules by chromosome tethering. J Cell Sci (2001) 1.00
Uptake and scanning of the salivary glands in man using pertechnetate-99m-Tc. Clin Sci (1967) 1.00
Translumbar puncture of a renal hydatid cyst. Br J Radiol (1973) 0.99
Axillary acne agminata (lupus miliaris disseminatus faciei). Clin Exp Dermatol (1998) 0.99
Remission of thyrotoxicosis during treatment with propranolol. Br Med J (1973) 0.98
Peroxidase activity in relation to iodide, 17 beta-oestradiol and thioureylene drug uptake in human polymorphoneutrophils. Biochem Pharmacol (1984) 0.98
Plastic insulin syringes: reuse or waste pounds 8m a year. Br Med J (Clin Res Ed) (1988) 0.98
Recording the pattern of salivary flow. J Dent Res (1967) 0.98
The calibration of bicycle ergometers. Can J Physiol Pharmacol (1968) 0.97
Excretion of carbimazole and propylthiouracil in breast milk. Lancet (1979) 0.96
Biguanides and lacticacidosis. Lancet (1977) 0.96
Total thyroidal content of iodine in thyrotoxic patients measured by in vivo neutron activation analysis. Clin Endocrinol (Oxf) (1976) 0.95
Influence of iodine intake after treatment with antithyroid drugs. Lancet (1965) 0.95
Results of treatment of thyrotoxicosis after postoperative relapse. Br Med J (1969) 0.95
Self-limiting episodes of recurrent thyrotoxicosis. Lancet (1971) 0.94
Neuroendocrine influences on visual discrimination and reversal learning in the albino and hooded rat. Physiol Behav (1973) 0.94
The acclumulation of 35 S-antithyroid drugs by the thyroid gland. J Clin Endocrinol Metab (1972) 0.93
Erysipelothrix septicaemia. Br Med J (1973) 0.93
Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf) (1998) 0.92
The relation between salivary iodide excretion and the plasma inorganic iodine concentration. Q J Exp Physiol Cogn Med Sci (1966) 0.92
Intrauterine hypothyroidism due to antithyroid-drug therapy for thyrotoxicosis during pregnancy. Lancet (1978) 0.91
The urinary sodium: potassium ratio and response to diuretics in resistant oedema. Postgrad Med J (1977) 0.90
The application of HPLC to the determination of some 1,4 benzodiazepines and their metabolites in plasma. Br J Clin Pharmacol (1978) 0.90
Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs. Metabolism (1969) 0.90
In vivo measurement of the intrathyroidal iodine concentration in man by activation analysis. J Clin Endocrinol Metab (1968) 0.89
Studies of the thyroid iodide "trap" in man. Recent Prog Horm Res (1969) 0.89
Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs. J Clin Endocrinol Metab (1966) 0.89
Identification of 3-methyl-2-thiohydantoin, a metabolite of carbimazole, in man. Xenobiotica (1977) 0.89
Early diastolic murmurs in end-stage renal failure. Br Heart J (1977) 0.88
A photosensitising adenovirus for photodynamic therapy. Gene Ther (1999) 0.88
Thyroidal uptake and turnover of the pertechnetate ion in normal and hyperthyroid subjects. J Clin Endocrinol Metab (1968) 0.88
Development and comparison of thin-layer chromatographic and gas-liquid chromatographic methods for measurement of methimazole in rat urine. J Chromatogr (1970) 0.88
Thyroidal iodide tranpsort. 8. Endocrinology (1966) 0.88
Use of capillary electrophoresis in the study of ligand-DNA interactions. Nucleic Acids Res (1998) 0.87
Loss of pertechnetate from the human thyroid. J Nucl Med (1969) 0.87
Transient hypothyroidism following radioiodine therapy for thyrotoxicosis. Br J Radiol (1983) 0.86
Computer vision syndrome: a study of knowledge and practices in university students. Nepal J Ophthalmol (2013) 0.86
Treatment of thyrotoxicosis based on thyroidal suppressiblity. Lancet (1967) 0.85
Sister chromatid exchange in lymphocytes from patients with acute lymphoblastic leukemia. Hum Genet (1979) 0.85
Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy. Eur J Nucl Med (1984) 0.85
Lung cancer and allergy. Br J Clin Pract (1972) 0.85
Long-term results of free vascularized fibular graft. A clinical and radiographic evaluation. Clin Orthop Relat Res (1995) 0.85
Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions. Biochem J (1996) 0.85
A comparison between the inhibitory effect of perchlorate on iodide and pertechnetate concentrations in saliva in man. Q J Exp Physiol Cogn Med Sci (1968) 0.84
Quantitative aspects of the inhibitory effect of the iodide ion on parotid salivary iodide and pertechnetate secretion in man. J Lab Clin Med (1968) 0.84
The relation between the clearance of iodide and pertechnetate in human parotid saliva and salivary flow rate. Clin Sci (1967) 0.84
Metabolism of 35S-labelled antithyroid drugs in man. Br Med J (1969) 0.84
Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination. Pharmeur Sci Notes (2006) 0.83
The characterisation and quantitation by high-performance liquid chromatography of the metabolites of taurolin. Br J Clin Pharmacol (1981) 0.83
Effect of calcium on iodine metabolism in man. Metabolism (1967) 0.82
Letter: Guanethidine in hypertension. Br Med J (1976) 0.82
Quantitation of thyroidal binding of iodide by compartmental analysis verified by an intravenous perchlorate discharge test. Eur J Nucl Med (1980) 0.82
Metabolism of the dihydropyridine calcium channel blockers mebudipine and dibudipine by isolated rat hepatocytes. J Pharm Pharmacol (2004) 0.82
Dowling Degos disease in association with multiple seborrhoeic warts. Clin Exp Dermatol (1997) 0.82
The salivary iodide trap in nontoxic goiter. J Clin Endocrinol Metab (1968) 0.82
Improved method for the determination of methimazole in plasma by high-performance liquid chromatography. J Chromatogr (1976) 0.82
99mTc-pertechnetate for measuring thyroid suppressibility. J Nucl Med (1971) 0.82
The pharmacokinetics and pharmacodynamics of bumetanide in normal subjects. J Pharmacokinet Biopharm (1982) 0.82
Hyponatraemia and seizures after ecstasy use. Postgrad Med J (1999) 0.82
A case of a giant cystic lymphangioma mimicking acute appendicitis. Ann R Coll Surg Engl (2012) 0.82
Membrane fusion is induced by a distinct peptide sequence of the sea urchin fertilization protein bindin. J Biol Chem (1998) 0.81
The salivary and thyroid glands. A comparative study in man. Br Dent J (1967) 0.81